Private Wealth Management Group’s 10x Genomics TXG Stock Holding History

Private Wealth Management Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.1K	Hold	395	–	–	﹤0.01%	461
2026 Q1	$8.39K	Hold	395	–	–	﹤0.01%	582
2025 Q4	$6.44K	Hold	395	–	–	﹤0.01%	675
2025 Q3	$4.62K	Hold	395	–	–	﹤0.01%	821
2025 Q2	$4.58K	Buy	395 +198	+101%	+$1.8K	﹤0.01%	793
2025 Q1	$1.72K	Buy	+197	New	+$2.48K	﹤0.01%	1102
2024 Q4	–	Sell	-127	Closed	-$2.87K	–	1576
2024 Q3	$2.87K	Hold	127	–	–	﹤0.01%	940
2024 Q2	$2.47K	Buy	127 +100	+370%	+$2.62K	﹤0.01%	978
2024 Q1	$1.01K	Hold	27	–	–	﹤0.01%	1264
2023 Q4	$1.51K	Buy	+27	New	+$1.18K	﹤0.01%	1099

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Wealth Management Group's TXG Position: Q2 2026 in Review

Private Wealth Management Group held its 10x Genomics (TXG) position steady in Q2 2026 at 395 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Private Wealth Management Group first reported a position in TXG in Q4 2023 and has held it in 10 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Private Wealth Management Group held 395 shares of 10x Genomics worth $15.1K as of Q2 2026.
Private Wealth Management Group left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #461 holding.
Private Wealth Management Group first reported a position in 10x Genomics in Q4 2023 and has held it in 10 quarters since.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.